Illustration: Sarah Grillo/Axios

Facebook on Thursday sued OneAudience, a mobile data analytics company, for collecting data from its users beginning in September 2019.

Details: Facebook alleges that OneAudience plugged software development kits (SDK) — designed to scrape user data from its site as well as Google and Twitter — into shopping and gaming apps distributed through stores like Google Play.

How it works: People would have their data collected after downloading an app and logging into it through their Google, Facebook or Twitter account, Facebook claims in the lawsuit.

The company says that users' names, email addresses, time zones, the country in which the account is used, user ID (a string of numbers that links someone to their profile) and in some cases, gender, were collected by OneAudience.

  • Gender was not obtained by OneAudience unless the user authorized an app to know it.
  • Instagram was not affected, Facebook spokesperson Jason Grosse told Axios.
  • OneAudience said that the data it collected was "deleted on a regular basis from OneAudience's data systems," per Facebook's lawsuit.

What they're saying: "This is the latest in our efforts to protect people and increase accountability of those who abuse the technology industry and users," Jessica Romero, Facebook's director of platform enforcement and litigation, wrote in a blog post on Thursday.

  • OneAudience did not immediately respond to a request for comment. In November, the company said it shut down the OneAudience SDK, stating that personal information was "never intended to be collected, never added to our database and never used."
  • Twitter users' emails, usernames and last Tweets were reportedly affected by OneAudience scraping, the company wrote in a November blog post. Twitter said it had evidence of Android users being affected, but not iOS users.

Go deeper: Facebook finally gives researchers access to promised data

Go deeper

Dan Primack, author of Pro Rata
1 hour ago - Economy & Business

GoodRx prices IPO at $33 per share, valued at $12.7 billion

Illustration: Sarah Grillo/Axios

GoodRx, a price comparison app for prescription drugs at local pharmacies, on Tuesday night raised $1.14 billion in its IPO, Axios has learned.

By the numbers: GoodRx priced its shares at $33 a piece, above its $24-$28 per share offering range, which will give it an initial market cap of around $12.7 billion.

Updated 1 hour ago - Politics & Policy

House Democrats and Trump admin strike deal to avert government shutdown

House Speaker Nancy Pelosi on Capitol Hill. Photo: Tom Williams/CQ-Roll Call via Getty Images

The House on Tuesday passed legislation to fund the government through Dec. 11, by a vote of 359-57.

Why it matters: The bill will avert a government shutdown when funding expires in eight days. Pelosi and House Majority Leader Steny Hoyer (D-Md.) said earlier that they hoped to hold a vote on the legislation on Tuesday evening.

2 hours ago - Politics & Policy

Scoop: Meadows puts agencies on notice about staff shake-up

Internal government email obtained by Axios

White House chief of staff Mark Meadows told administration officials Monday to expect senior aides to be replaced at many government agencies, according to an internal email obtained by Axios.

Behind the scenes: Meadows asked the director of the White House Presidential Personnel Office John McEntee "to look at replacing the White House Liaisons (WHLs) at many of your agencies," according to the email. "John will be working with outgoing liaisons to explore other opportunities."

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!